Subcutaneous Calcitonin in Acute Herpes Zoster
Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age50+
SponsorTanta University
About this trial
This prospective randomized controlled study will be conducted to evaluate the effect of adding calcitonin to the standard treatment protocol in patients with acute herpes zoster infection.
Eligibility criteria
Qualifiers
patients aged ≥ 50 years, with acute herpes zoster infection (rash duration < 7 days) and moderate to severe pain.
Disqualifiers
Coagulation abnormalities
Pre-existing other pain syndrome or psychological disorders.
Severe hepatic, cardiovascular, or renal disorders.
Allergy to calcitonin.
Trial design
Treatments tested in this trial
- Calcitonin
- Saline
Treatment groups
168 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov